Cargando…

Dipeptidyl peptidase 4 expression is not associated with an activated fibroblast phenotype in idiopathic pulmonary fibrosis

Dipeptidyl peptidase 4 (DPP4) has been proposed as a marker for activated fibroblasts in fibrotic disease. We aimed to investigate whether a profibrotic DPP4 phenotype is present in lung tissue from patients with idiopathic pulmonary fibrosis (IPF). The presence of DPP4(+) fibroblasts in normal and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadefors, Måns, Berlin, Frida, Wildt, Marie, Dellgren, Göran, Rolandsson Enes, Sara, Aspberg, Anders, Westergren-Thorsson, Gunilla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473336/ https://www.ncbi.nlm.nih.gov/pubmed/36120350 http://dx.doi.org/10.3389/fphar.2022.953771

Ejemplares similares

CD105(+)CD90(+)CD13(+) identifies a clonogenic subset of adventitial lung fibroblasts
por: Kadefors, Måns, et al.
Publicado: (2021)

Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases
por: Elowsson Rendin, Linda, et al.
Publicado: (2021)

Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics
por: Weitoft, Maria, et al.
Publicado: (2022)

Matrisome Properties of Scaffolds Direct Fibroblasts in Idiopathic Pulmonary Fibrosis
por: Elowsson Rendin, Linda, et al.
Publicado: (2019)

Alveolar epithelial cells are competent producers of interstitial extracellular matrix with disease relevant plasticity in a human in vitro 3D model
por: Rosmark, Oskar, et al.
Publicado: (2023)

New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
por: Cui, Chenkai, et al.
Publicado: (2022)

Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary Fibrosis
por: Kalafatis, Dimitrios, et al.
Publicado: (2021)

Soluble Dipeptidyl Peptidase-4 Induces Fibroblast Activation Through Proteinase-Activated Receptor-2
por: Lee, Shih-Yi, et al.
Publicado: (2020)

Temporal trend of autonomic nerve function and HSP27, MIF and PAI-1 in type 1 diabetes
por: Zimmerman, Malin, et al.
Publicado: (2017)

Dipeptidyl peptidase-4 and kidney fibrosis in diabetes
por: Shi, Sen, et al.
Publicado: (2016)

Effect of Dipeptidyl Peptidase-4 Inhibitors on Bone Metabolism and the Possible Underlying Mechanisms
por: Yang, Yinqiu, et al.
Publicado: (2017)

Risk of Cardiovascular Events and Medical Cost of Dapagliflozin and Dipeptidyl Peptidase-4 Inhibitors
por: Seong, Jong-Mi, et al.
Publicado: (2021)

Mitochondrial Dysfunction in Lung Resident Mesenchymal Stem Cells from Idiopathic Pulmonary Fibrosis Patients
por: Mercader-Barceló, Josep, et al.
Publicado: (2023)

Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
por: Esaki, Hiroki, et al.
Publicado: (2017)

Quantitative proteomic characterization of lung-MSC and bone marrow-MSC using DIA-mass spectrometry
por: Rolandsson Enes, Sara, et al.
Publicado: (2017)

Dipeptidyl Peptidase-4 and Adolescent Idiopathic Scoliosis: Expression in Osteoblasts
por: Normand, Emilie, et al.
Publicado: (2017)

A tunable physiomimetic stretch system evaluated with precision cut lung slices and recellularized human lung scaffolds
por: Rosmark, Oskar, et al.
Publicado: (2022)

Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis
por: Habiel, David M., et al.
Publicado: (2014)

The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
por: Zhang, Tianli, et al.
Publicado: (2021)

Activated MC(TC )mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis
por: Andersson, Cecilia K, et al.
Publicado: (2011)

Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study
por: Hamberg, Viggo, et al.
Publicado: (2023)

Crosstalk between Mast Cells and Lung Fibroblasts Is Modified by Alveolar Extracellular Matrix and Influences Epithelial Migration
por: Bagher, Mariam, et al.
Publicado: (2021)

Impaired Differentiation of Chronic Obstructive Pulmonary Disease Bronchial Epithelial Cells Grown on Bronchial Scaffolds
por: Hedström, Ulf, et al.
Publicado: (2021)

Enhanced ROCK1 dependent contractility in fibroblast from chronic obstructive pulmonary disease patients
por: Hallgren, Oskar, et al.
Publicado: (2012)

Altered fibroblast proteoglycan production in COPD
por: Hallgren, Oskar, et al.
Publicado: (2010)

Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors
por: Shibasaki, Ikuko, et al.
Publicado: (2022)

hLMSC Secretome Affects Macrophage Activity Differentially Depending on Lung-Mimetic Environments
por: Falcones, Bryan, et al.
Publicado: (2022)

Development of a physiomimetic model of acute respiratory distress syndrome by using ECM hydrogels and organ-on-a-chip devices
por: Marhuenda, Esther, et al.
Publicado: (2022)

Evolutionary Analysis of Dipeptidyl Peptidase I
por: Varda, Nina, et al.
Publicado: (2022)

Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome
por: Birnbaum, Yochai, et al.
Publicado: (2016)

Beta-endoproteolysis of the cellular prion protein by dipeptidyl peptidase-4 and fibroblast activation protein
por: Castle, Andrew R., et al.
Publicado: (2022)

Dipeptidyl Peptidase-4 Inhibitors Use and Relative Risk of Ischemic Cerebrovascular Disease in Type 2 Diabetic Patients in a Case-Control Study
por: Lai, Shih-Wei, et al.
Publicado: (2017)

Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors vs. Dipeptidyl Peptidase-4 Inhibitors in Frail People With Diabetes Who Were Recently Hospitalized
por: Wood, Stephen J, et al.
Publicado: (2022)

Ciliated (FOXJ1(+)) Cells Display Reduced Ferritin Light Chain in the Airways of Idiopathic Pulmonary Fibrosis Patients
por: Wijk, Sofia C., et al.
Publicado: (2022)

Aberrant nonfibrotic parenchyma in idiopathic pulmonary fibrosis is correlated with decreased β‐catenin inhibition and increased Wnt5a/b interaction
por: Rydell‐Törmänen, Kristina, et al.
Publicado: (2016)

MSC from fetal and adult lungs possess lung-specific properties compared to bone marrow-derived MSC
por: Rolandsson Enes, Sara, et al.
Publicado: (2016)

First-in-Human, Double-Blind, Randomized, Placebo-Controlled Trial of TQ-F3083, a New Dipeptidyl Peptidase-4 Inhibitor, in Healthy Chinese Adults
por: Liu, Jingrui, et al.
Publicado: (2021)

Impact of glucagon-like peptide 1 receptor agonist liraglutide and dipeptidyl peptidase-4 inhibitor sitagliptin on bowel cleaning and gastrointestinal symptoms in type 2 diabetes
por: Tong, Yan, et al.
Publicado: (2023)

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
por: Kim, Na-Hyung, et al.
Publicado: (2014)

Tackling dipeptidyl peptidase IV in neurological disorders
por: Al-Badri, Ghaith, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eh0j3kucllk5l20i0fiuj1uh3r